GSK Announces Positive CHMP Opinion in Europe for Severe Refractory Eosinophilic Asthma Drug Mepolizumab
Asthma, News
GlaxoSmithKline, a leading research-based pharmaceutical and healthcare company, recently announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended marketing authorization ... Read more